Chengdong Liu
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
-
- RNA modifications and cancer 7
- Ginseng Biological Effects and Applications 2
-
- Cancer Immunotherapy and Biomarkers 4
-
- Ferroptosis and cancer prognosis 4
Chengdong Liu
16 papers receiving 392 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 230
- Molecular Biology 253
- Oncology 79
- Sensory Systems 13
- Immunology 54
Countries citing papers authored by Chengdong Liu
This map shows the geographic impact of Chengdong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengdong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengdong Liu more than expected).
Fields of papers citing papers by Chengdong Liu
This network shows the impact of papers produced by Chengdong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengdong Liu. The network helps show where Chengdong Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chengdong Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 62 | |
| 9 | 2021 | 35 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 25 | |
| 13 | 2020 | 33 | |
| 14 | 2019 | 30 | |
| 15 | 2018 | 97 | |
| 16 | 2018 | 69 |
About Chengdong Liu
Chengdong Liu is a scholar working on Cancer Research, Sensory Systems and Immunology, having authored 16 papers that have together received 394 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (4 papers), Ginseng Biological Effects and Applications (2 papers), Cancer, Lipids, and Metabolism (2 papers), MicroRNA in disease regulation (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (230 citations), Molecular Biology (253 citations) and Oncology (79 citations). Chengdong Liu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Dehua Wu, Li Liu, Xiaohan Zhou, Shengni Hua, Yuting Chen, Jun Du, Ling Deng, Chuanhui Cao, Xiaolong Qi and Dongyan Zhang. Their work appears in journals such as Oncogene, Biochemical and Biophysical Research Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.